Kindbody
Rightway will integrate the New York-based company's hybrid fertility and reproductive care platform into its ecosystem partnership program.
The funds will be used to expand its reach.
The funds will be used to open new clinics in the U.S.
Amplo led the capital raise for the surrogacy connection platform.
The deal with Alternative Reproductive Resources is Kindbody's third so far this year.
This marks the company's second deal this year. It announced plans to acquire a network of fertility clinics in February.
The addition of Vios' network of fertility clinics will bring Kindbody's national location count to 26.
The male and female hormone tests are the first product in the company's Kind at Home consumer products division.
Also: Truepill to expand digital pharmacy business with $25 million Series B; Nucleai's precision oncology platform gains $6.5 million from Debiopharm.
The company plans on using the new funds to expand its services to new locations.